Spots Global Cancer Trial Database for Phase I Study in Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase I Study in Advanced Solid Tumors
Official Title: IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors
Study ID: NCT00591292
Conditions
Interventions
Study Description
Brief Summary: Dose escalating study of orally administered indibulin at twice daily schedule in subjects with solid tumors.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Santa Monica, California, United States
Contact Details
Name: Jonathan Lewis, MD
Affiliation: Alaunos Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
